NM_080860.4:c.680delA
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_080860.4(RSPH1):c.680delA(p.Lys227SerfsTer38) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,602 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_080860.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 24Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_080860.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RSPH1 | TSL:1 MANE Select | c.680delA | p.Lys227SerfsTer38 | frameshift | Exon 7 of 9 | ENSP00000291536.3 | Q8WYR4-1 | ||
| RSPH1 | c.608delA | p.Lys203SerfsTer38 | frameshift | Exon 6 of 8 | ENSP00000526578.1 | ||||
| RSPH1 | TSL:5 | c.566delA | p.Lys189SerfsTer38 | frameshift | Exon 6 of 8 | ENSP00000381395.3 | Q8WYR4-2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461602Hom.: 0 Cov.: 34 AF XY: 0.00000138 AC XY: 1AN XY: 727092 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 34
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at